Tags

Type your tag names separated by a space and hit enter

Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study.
Diabetes Technol Ther. 2010 Aug; 12(8):591-7.DT

Abstract

BACKGROUND

Commercial continuous subcutaneous glucose monitors require in vivo calibration using capillary blood glucose tests. Feasibility of factory calibration, i.e., sensor batch characterization in vitro with no further need for in vivo calibration, requires a predictable and stable in vivo sensor sensitivity and limited inter- and intra-subject variation of the ratio of interstitial to blood glucose concentration.

METHODS

Twelve volunteers wore two FreeStyle Navigator (Abbott Diabetes Care, Alameda, CA) continuous glucose monitoring systems for 5 days in parallel for two consecutive sensor wears (four sensors per subject, 48 sensors total). Sensors from a prototype sensor lot with a low variability in glucose sensitivity were used for the study. Median sensor sensitivity values based on capillary blood glucose were calculated per sensor and compared for inter- and intra-subject variation. Mean absolute relative difference (MARD) calculation and error grid analysis were performed using a single calibration factor for all sensors to simulate factory calibration and compared to standard fingerstick calibration.

RESULTS

Sensor sensitivity variation in vitro was 4.6%, which increased to 8.3% in vivo (P < 0.0001). Analysis of variance revealed no significant inter-subject differences in sensor sensitivity (P = 0.134). Applying a single universal calibration factor retrospectively to all sensors resulted in a MARD of 10.4% and 88.1% of values in Clarke Error Grid Zone A, compared to a MARD of 10.9% and 86% of values in Error Grid Zone A for fingerstick calibration.

CONCLUSIONS

Factory calibration of sensors for continuous subcutaneous glucose monitoring is feasible with similar accuracy to standard fingerstick calibration. Additional data are required to confirm this result in subjects with diabetes.

Authors+Show Affiliations

Abbott Diabetes Care, Alameda, CA 94502, USA. udo.hoss@abbott.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20615099

Citation

Hoss, Udo, et al. "Continuous Glucose Monitoring in Subcutaneous Tissue Using Factory-calibrated Sensors: a Pilot Study." Diabetes Technology & Therapeutics, vol. 12, no. 8, 2010, pp. 591-7.
Hoss U, Jeddi I, Schulz M, et al. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study. Diabetes Technol Ther. 2010;12(8):591-7.
Hoss, U., Jeddi, I., Schulz, M., Budiman, E., Bhogal, C., & McGarraugh, G. (2010). Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study. Diabetes Technology & Therapeutics, 12(8), 591-7. https://doi.org/10.1089/dia.2010.0051
Hoss U, et al. Continuous Glucose Monitoring in Subcutaneous Tissue Using Factory-calibrated Sensors: a Pilot Study. Diabetes Technol Ther. 2010;12(8):591-7. PubMed PMID: 20615099.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study. AU - Hoss,Udo, AU - Jeddi,Iman, AU - Schulz,Mark, AU - Budiman,Erwin, AU - Bhogal,Claire, AU - McGarraugh,Geoffrey, PY - 2010/7/10/entrez PY - 2010/7/10/pubmed PY - 2010/10/12/medline SP - 591 EP - 7 JF - Diabetes technology & therapeutics JO - Diabetes Technol Ther VL - 12 IS - 8 N2 - BACKGROUND: Commercial continuous subcutaneous glucose monitors require in vivo calibration using capillary blood glucose tests. Feasibility of factory calibration, i.e., sensor batch characterization in vitro with no further need for in vivo calibration, requires a predictable and stable in vivo sensor sensitivity and limited inter- and intra-subject variation of the ratio of interstitial to blood glucose concentration. METHODS: Twelve volunteers wore two FreeStyle Navigator (Abbott Diabetes Care, Alameda, CA) continuous glucose monitoring systems for 5 days in parallel for two consecutive sensor wears (four sensors per subject, 48 sensors total). Sensors from a prototype sensor lot with a low variability in glucose sensitivity were used for the study. Median sensor sensitivity values based on capillary blood glucose were calculated per sensor and compared for inter- and intra-subject variation. Mean absolute relative difference (MARD) calculation and error grid analysis were performed using a single calibration factor for all sensors to simulate factory calibration and compared to standard fingerstick calibration. RESULTS: Sensor sensitivity variation in vitro was 4.6%, which increased to 8.3% in vivo (P < 0.0001). Analysis of variance revealed no significant inter-subject differences in sensor sensitivity (P = 0.134). Applying a single universal calibration factor retrospectively to all sensors resulted in a MARD of 10.4% and 88.1% of values in Clarke Error Grid Zone A, compared to a MARD of 10.9% and 86% of values in Error Grid Zone A for fingerstick calibration. CONCLUSIONS: Factory calibration of sensors for continuous subcutaneous glucose monitoring is feasible with similar accuracy to standard fingerstick calibration. Additional data are required to confirm this result in subjects with diabetes. SN - 1557-8593 UR - https://www.unboundmedicine.com/medline/citation/20615099/Continuous_glucose_monitoring_in_subcutaneous_tissue_using_factory_calibrated_sensors:_a_pilot_study_ L2 - https://www.liebertpub.com/doi/10.1089/dia.2010.0051?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -